Existing IPF treatments, including Boehringer’s recently approved Jascayd, slow disease progress rather than halt or reverse ...

Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue.

When you think about diseases that affect the lungs, like chronic obstructive pulmonary disease (COPD), there are likely some ...

When Amy was first diagnosed with scleroderma, she never imagined it would lead to a lifelong journey with lung disease.

The Department of Anesthesiology and Intensive Care Medicine at the Carl Gustav Carus University Hospital in Dresden and the TU Dresden Faculty of Medicine has conducted the world's largest study on ...

Good medical care is essential for patients with idiopathic pulmonary fibrosis. But navigating daily life with the disease ...

Using coronary artery calcium scores alongside cardiovascular risk scores better identifies patients with chronic obstructive pulmonary disease at a high risk for major adverse cardiovascular events.

In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this report, we follow up on what has happened since. After the FDA approved both ...

FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...

A pulmonary embolism (PE) is a blockage in one of the arteries in your lungs. Arteries are the blood vessels that carry blood away from the heart to the organs, muscles, and other tissue. Most of the ...

The pulmonary valve is located between the right ventricle and the pulmonary artery. The valve acts as a doorway that lets blood into and out of the heart. Pulmonary valve stenosis is when the ...